Search Results
Results found for "Xiaonong Li"
Posts (490)
- What's Going On with GPCRs?! Find Out in This Week's Update! ⦿ Nov 4 - 10, 2024
GPCR-BSD: a database of binding sites of human G-protein coupled receptors under diverse states Fan Liu , Han Zhou , Xiaonong Li , Liangliang Zhou , Chungong Yu , Haicang Zhang , Dongbo Bu 🤩 Seriously, why GPCR Events to keep you informed and engaged GPCR Jobs connecting candidates with positions Direct line This strategic decision to limit free content is essential as we need to increase revenue to support
- A robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery.
assay and Kd= 42nM in Tag-lite®). Competition experiments of binding of fluorescent ligand CELT-335 to living HEK-293 T cells expressing W.; Wu, Y.; Zhao, S.; Shui, W.; Li, S.; Korde, A.; Laprairie, R. B.; Stahl, E. L.; Ho, J. Cell 2016 , 167 (3), 750-762.e14. https://doi.org/10.1016/j.cell.2016.10.004 . (5) Li, X.; A Fluorescent Ligand-Binding Alternative Using Tag-Lite® Technology.
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
GPCR-focused programs, the ability to visualize receptor localization, internalization kinetics, and ligand Yet, despite remarkable progress, HCS workflows remain vulnerable to several performance-limiting factors How Fluorescent Ligands Strengthen HCS Assays: The Case of CELT-331 Fluorescent ligands are now considered Their ability to visualize ligand–receptor interactions directly in living cells produces data that are information that clarifies receptor behavior under different ligand conditions.
Other Pages (337)
- Dr. Nicolas Gilles | Dr. GPCR Ecosystem
<< Back to podcast list Dr. GPCR Podcast Strategic Partners Dr. Nicolas Gilles About Dr. His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations When the pharmacological properties of these new ligands are deemed exceptional, a lead optimization Nicolas Gilles on the web Google Scholar LinkedIn Dr. GPCR Enjoying the Dr. GPCR Podcast? : The Evolution of GPCR Research How GPCR Spatial Signaling Sparked a Scientific Journey Thanks for listening
- Terry's Corner is Officially LIVE! 🎉 This is your new go-to for mastering drug discovery pharmacology. No fluff, just clear, on-demand insights from Terry Kenakin. Building core expertise? Master dose-response, binding, kinetics, and foundational models. Driving drug discovery? Apply pharmacology to selectivity, ADME, and strategic decision-making. An experienced drug hunter? Sharpen your edge with allosteric bias, residence time, and translational PK/PD. Learn on-demand, apply immediately: https://terrykenakin.com #DrGPCR #GPCR #pharmacology #TerrysCorner #DrugDiscovery | Dr. GPCR Ecosystem
Home → Flash News → Terry's Corner is Officially LIVE! TerrysCorner #DrugDiscovery Published on July 2, 2025 Category Terry's Corner Terry's Corner is Officially LIVE But what if the real opportunity lies in the chemical matter we throw at them?
- ep 175 with jens carlsson clip 3 | Dr. GPCR Ecosystem
For decades, molecular modeling focused on explaining — rationalizing why a ligand binds, why a mutation With tools like AlphaFold , his lab can now model receptor–peptide complexes in seconds — an achievement A good model doesn’t just match published structures; it forecasts new biology, new ligands, and new That’s where the future of GPCR research lies — not in describing the past, but in anticipating it.
Events (2)
- Development of GPCR Ligands as Therapeutic DrugsTickets: $0.00March 20, 2025 | 2:00 PM
- The Practical Assessment of Signaling BiasTickets: $306.48February 20, 2025 | 3:00 PM






